RADX Radiopharm Theranostics Limited

NASDAQ
$2.44

Radiopharm Theranostics Limited (RADX) is expected to report earnings on July 29, 2025, before the market open. The consensus earnings estimate is a loss of $0.01 per share.

Earnings Date
4th Quarter, Jun 2026
Jul 29
Tuesday · Before Open
Earnings Whisper
-
vs ($0.01)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Radiopharm Theranostics Limited

Radiopharm Theranostic is a clinical-stage biopharmaceutical company focused on developing oncology radiopharmaceuticals for areas of high unmet medical need. Radiopharm Theranostic is based in SYDNEY.

Sector

Healthcare

Industry

Biotechnology